Review of Botanical Drugs for Cervical HPV Infection

A 48.0 KB review document authored by Yan-Cai Tang, last updated on 2026-04-30. It synthesizes evidence on botanical drugs and their metabolites as potential adjunctive interventions for persistent cervical human papillomavirus infection, focusing on therapeutic outputs like HPV oncogene suppression and viral DNA disruption.

Use Cases

• Identify botanical compounds associated with HPV oncogene suppression based on the reviewed literature.
• Analyze gaps in phytochemical characterization and pharmacokinetic data for botanical drugs mentioned in the review.
• Design genotype-stratified study protocols based on the review's discussion of heterogeneous evidence.
• Evaluate the relevance of experimental models used in cervical HPV studies as critiqued in the document.

Strengths

• Document is under a permissive CC-BY-4.0 license.
• The review critically organizes evidence around experimentally interpretable therapeutic outputs.
• File size is precisely 48.0 KB.

Limitations

• The dataset is a single 48.0 KB DOCX review document, not a primary data collection.
• Row count and column-level documentation are absent; the content is narrative.
• The description notes the reviewed evidence is heterogeneous and limited by incomplete phytochemical characterization and variable experimental models.

Provenance

Source

figshare

Collection Method

Authored review article.

Freshness

Last updated 2026-04-30 05:40:32; freshness should be verified.